Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure. - Wikidata - awgldk - TriplyDB

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.

http://www.wikidata.org/entity/Q43919813

about

Coenzyme Q10 for heart failure Coenzyme Q10 for heart failure Coenzyme Q10 for the treatment of heart failure: a review of the literature Glycemic variability and glycemic control in the acutely ill cardiac patient Clinical adoption of prognostic biomarkers: the case for heart failure Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases Induction of brain natriuretic peptide and monocyte chemotactic protein-1 gene expression by oxidized low-density lipoprotein: relevance to ischemic heart failure Physiological and therapeutic regulation of PCSK9 activity in cardiovascular disease.Statins and dilated cardiomyopathy: do we have enough data?How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review The Dynamics of Oxidized LDL during Atherogenesis.Relation of baseline plasma phospholipid transfer protein (PLTP) activity to left ventricular systolic dysfunction in patients referred for coronary angiography.Reactive oxygen species in cardiovascular disease.The role of erythropoietin in myocardial protection: potential mechanisms and applications.Anti-oxidized low-density lipoprotein antibodies in chronic heart failure.Determinants and clinical significance of plasma oxidized LDLs in older individuals. A 9 years follow-up study Increased presence of oxidized low-density lipoprotein in the left ventricular blood of subjects with cardiovascular disease.The influence of atorvastatin on parameters of inflammation left ventricular function, hospitalizations and mortality in patients with dilated cardiomyopathy--5-year follow-up.The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts.Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?New and emerging biomarkers of heart failure.Role of the excessive amounts of circulating catecholamines and glucocorticoids in stress-induced heart disease.Markers of Oxidative Stress in Dogs with Myxomatous Mitral Valve Disease are Influenced by Sex, Neuter Status, and Serum Cholesterol Concentration.Risk stratification and short-term prognosis in acute heart failure syndromes: a review of novel biomarkers.Oxidized LDL, LOX-1 and atherosclerosis.New and emerging biomarkers in left ventricular systolic dysfunction--insight into dilated cardiomyopathy.Oxidized low-density lipoprotein as a biomarker of cardiovascular diseases.Coenzyme Q10 and Utility in Heart Failure: Just Another Supplement?MiR-216a: a link between endothelial dysfunction and autophagy.Oxidized low-density lipoprotein (oxLDL) affects load-free cell shortening of cardiomyocytes in a proprotein convertase subtilisin/kexin 9 (PCSK9)-dependent way.Oxidized Low-Density Lipoprotein Induces Apoptosis in Cultured Neonatal Rat Cardiomyocytes by Modulating the TLR4/NF-κB Pathway.Oxidized Low Density Lipoprotein and High Sensitive C-Reactive Protein in Non-Diabetic, Pre-Diabetic and Diabetic Patients in the Acute Phase of the First Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.Ascorbic acid does not affect the age-associated reduction in maximal cardiac output and oxygen consumption in healthy adults.Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.Effect of simvastatin vs. rosuvastatin on adiponectin and haemoglobin A1c levels in patients with non-ischaemic chronic heart failure.Effect of the Mediterranean diet on heart failure biomarkers: a randomized sample from the PREDIMED trial.Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy.Influence of experimental periodontitis on cardiac oxidative stress in rats: a biochemical and histomorphometric study.Oxidative stress in obstructive sleep apnoea.Oxidative stress and nitric oxide synthase in skeletal muscles of rats with post-infarction, compensated chronic heart failure.

P2860

Q24194154-D93699E1-4DE5-4662-B7BE-822ADA54190C Q24235690-0F4D8FC7-87AC-4FB0-A960-66534A3356AC Q26778097-1B85E84F-0E6E-48A1-B9D7-69F1CEE0430A Q26821994-DFFB7CD3-8C7A-414E-90E5-2BABD636595C Q26863716-BF068DD1-A9C9-4D2B-8D55-B3E26A563848 Q26866951-D5F2BFC8-DC11-4B29-BEBB-94499DAD3F7A Q28247437-AD04AB5B-8048-40FA-B98A-0FA784EF2870 Q33599961-79B3FD5A-902E-4B05-BF9B-8B19A0D11CED Q33787152-38F43303-BD9E-40CE-80E8-E51C5C653FFF Q33932889-C88706C7-BC25-4EB4-BBF1-FACA29845079 Q35024665-43B9E445-F23E-4A3C-A68E-A76065957E90 Q35153861-CC00330F-8880-446F-A1BF-36F04A92B6CA Q35165194-78A7FFC7-C78C-433E-9BB5-B75CBA9C46F0 Q36352011-39C1036B-AF5C-4E88-9419-FE9738EDF2FC Q36421852-BCC118A9-5F9A-437D-986D-5DBFAFCC59BE Q36487547-6B635F52-2BEC-430D-B853-598521A41443 Q36748282-38B268EE-F457-4BB0-9E15-009E8291BE8A Q36811609-A0519CB3-0492-4656-A075-9E413BAC2519 Q37275296-7C6E5EBD-4C38-4F13-BC85-1852A30B37B5 Q37355913-91883A8B-24DC-4E95-B79A-A46EA914B2F5 Q37514230-EA603572-84D8-4233-851D-EA2C5BE2C68E Q37600622-D8B00F92-433D-4EC6-8A92-7EDC6425ABC0 Q37705155-896624CB-506F-4DB9-B8E6-F5215EF91B96 Q37870921-06F2DAB3-51FA-4CC3-B6F5-A8A4C6463EBD Q37938848-75C14590-C81F-4269-BFF1-84BE53C1D1D6 Q38100987-943E9C69-4254-4F5B-A545-82B8F7FF4253 Q38299279-6588A812-6328-4152-9938-90F81EFCDA72 Q38873521-974CCFFC-27FE-4A65-BC0F-0EB7670CCE58 Q40138320-32AFC745-236B-4CAA-B8DC-FF608A8DF942 Q41874906-B98BCA25-1324-444D-9C20-490DFFA8D1A2 Q42069314-0FD984D1-EE02-46AD-B440-E7B2DB8624E0 Q42240864-0B0A06E2-91D9-4DE0-9056-145B7DA9F500 Q42638769-ACCFD188-7B71-4533-9CCD-0DC5D50D824F Q43072830-D70F62C6-F199-48C2-A9C5-D67347707857 Q43248481-44EDEECD-BDE4-4C08-8445-ADC5923486C1 Q43995630-5004CFE3-D74E-449D-BD90-480FC063F9A0 Q44805645-1445F798-A6A8-4EBA-B6FF-7D1439EAF726 Q46458350-68B1A612-3AB1-4B9C-8C09-289463B7AD90 Q46654980-1FBB8219-C647-4180-BA90-B05E044BCC6A Q46747273-6AF1CAF0-7987-4063-8E05-EACFC48A6385

P2860

Plasma oxidized low-density lipoprotein as a prognostic predictor in patients with chronic congestive heart failure.

http://www.wikidata.org/entity/Q43919813

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Plasma oxidized low-density li ...... onic congestive heart failure.

@en

Plasma oxidized low-density li ...... onic congestive heart failure.

@nl

type

label

Plasma oxidized low-density li ...... onic congestive heart failure.

@en

Plasma oxidized low-density li ...... onic congestive heart failure.

@nl

prefLabel

Plasma oxidized low-density li ...... onic congestive heart failure.

@en

Plasma oxidized low-density li ...... onic congestive heart failure.

@nl

P1433

Q43919813-883793E7-4114-424D-BD5D-459DEC7606C6

P1476

Q43919813-AA1D8695-FDB0-4708-9688-36009E9A293A

P2093

Q43919813-1CD8BB20-D89E-491B-A6B9-3AC1548A457D

Q43919813-30F31F5D-0F37-432B-B0AC-8BB3377CB697

Q43919813-4DF0B0A7-AD5A-4C61-A95C-E9ABB34138AE

Q43919813-667EC997-4D53-42AE-84A1-CE041759E4B7

Q43919813-C01697EF-1094-4D6B-83A6-959F3D9DD1FC

Q43919813-CC3A617F-B0B8-4A2E-996B-C36E7F494E9F

Q43919813-D31E701D-F017-432A-887E-8E3F5D55B7B9

Q43919813-EA03F48B-C659-41DD-A6EA-17D20121DEE1

P304

Q43919813-AAFD1015-BFDD-4428-ABB3-F5F9DB896A54

P31

Q43919813-3535E720-B4D2-47F6-BA1D-2900F9D0E7E1

P356

Q43919813-7FB21F8A-41AA-4B68-8C77-A024396D42E4

P407

Q43919813-633339CF-415A-42BB-8374-AFCDEB5ABC81

P433

Q43919813-C7115DA2-BFCD-47A5-926A-B82F8D14B0BF

P478

Q43919813-5A4F0F84-4607-41B6-8516-0CB1B69F121C

P577

Q43919813-E4D3DD80-AD06-4CDF-BFD2-A34A60BD5787

P698

Q43919813-A8907AB2-7B25-4453-A1E2-DEB74745B750

P921

Q43919813-8BE9D1A0-DF34-41EC-AC33-DA77A570497D

P356

S0735-1097(02)01721-7

P1433

Journal of the American College of Cardiology

P1476

Plasma oxidized low-density li ...... onic congestive heart failure.

@en

P2093

Atsuyuki Wada

http://www.w3.org/2001/XMLSchema#string

Keiko Maeda

http://www.w3.org/2001/XMLSchema#string

Masahiko Kinoshita

http://www.w3.org/2001/XMLSchema#string

Masaru Hayashi

http://www.w3.org/2001/XMLSchema#string

Masato Ohnishi

http://www.w3.org/2001/XMLSchema#string

Naoko Mabuchi

http://www.w3.org/2001/XMLSchema#string

Takashi Tsutsui

http://www.w3.org/2001/XMLSchema#string

Takayoshi Tsutamoto

http://www.w3.org/2001/XMLSchema#string

P304

957-962

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S0735-1097(02)01721-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

39

http://www.w3.org/2001/XMLSchema#string

P577

2002-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11897436

http://www.w3.org/2001/XMLSchema#string

P921